Literature DB >> 1833509

Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine.

F Moroni1, P Russi, M A Gallo-Mezo, G Moneti, R Pellicciari.   

Abstract

Quinolinic acid, an endogenous excitotoxin, and kynurenic acid, an antagonist of excitatory amino acid receptors, are believed to be synthesized from tryptophan after the opening of the indole ring. They were measured in the rat brain and other organs using gas chromatography-mass spectrometry or HPLC. The enzyme indoleamine 2,3-dioxygenase, capable of cleaving the indole ring of tryptophan, was induced by administering bacterial endotoxins to rats, which significantly increased the brain content of both quinolinic and kynurenic acids. Nicotinylalanine, an analogue of kynurenine, inhibited this endotoxin-induced accumulation of quinolinic acid while potentiating the accumulation of kynurenic acid. The possibility of significantly increasing brain concentrations of kynurenic acid without a concomitant increase in quinolinic acid may provide a useful approach for studying the role of these electrophysiologically active tryptophan metabolites in brain function and preventing the possible toxic actions of abnormal synthesis of quinolinic acid.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833509     DOI: 10.1111/j.1471-4159.1991.tb06361.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.

Authors:  Claudia Di Serio; Andrea Cozzi; Ilaria Angeli; Laura Doria; Isabella Micucci; Silvia Pellerito; Patrizia Mirone; Giulio Masotti; Flavio Moroni; Francesca Tarantini
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

2.  Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?

Authors:  H-Q Wu; A Rassoulpour; R Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

Review 3.  Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery.

Authors:  Flavio Moroni; Andrea Cozzi; Maria Sili; Guido Mannaioni
Journal:  J Neural Transm (Vienna)       Date:  2012-01-04       Impact factor: 3.575

4.  Role of kynurenines in the neurotoxic actions of kainic acid.

Authors:  W M Behan; T W Stone
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 5.  Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.

Authors:  D Zádori; P Klivényi; E Vámos; F Fülöp; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2009-07-18       Impact factor: 3.575

Review 6.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

Review 7.  IDO expression in the brain: a double-edged sword.

Authors:  Erik Kwidzinski; Ingo Bechmann
Journal:  J Mol Med (Berl)       Date:  2007-06-27       Impact factor: 4.599

8.  Isolation, characterization, and functional expression of kynurenine aminotransferase cDNA from the yellow fever mosquito, Aedes aegypti(1).

Authors:  J Fang; Q Han; J Li
Journal:  Insect Biochem Mol Biol       Date:  2002-08       Impact factor: 4.714

Review 9.  Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.

Authors:  R Schwarcz
Journal:  Adv Pharmacol       Date:  2016-03-11

Review 10.  The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects.

Authors:  K McCormack
Journal:  Drugs       Date:  1994       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.